Skip to content

- 我們的重點領域
- 產品列表
新聞
歐嘉隆台灣
加入我們

Main menu

Organon site directory

The Americas
- Organon
  
  Brazil
  
  Canada English · French
  
  Latin America
  
  Mexico
  
  USA
Europe
- Organon
  
  Austria
  
  Belgium Dutch · English · French
  
  Czech Republic
  
  Denmark
  
  Finland
  
  France
  
  Germany
  
  Ireland
  
  Italy
  
  Luxembourg English · French
  
  Netherlands Dutch · English
  
  Norway
  
  Portugal
  
  Russia
  
  Spain
  
  Sweden
  
  Switzerland
  
  United Kingdom
Asia Pacific
- Organon
  
  Australia
  
  Hong Kong, China
  
  Indonesia
  
  Japan
  
  Malaysia
  
  New Zealand
  
  Philippines
  
  Singapore
  
  South Korea
  
  Taiwan
  
  Thailand
  
  Vietnam
Middle East & Africa
- Organon
  
  Middle East English · Arabic
  
  Northwest Africa French · Arabic · Turkey
  
  South Africa

View all locations and contact information

What can we help you find?

Search site

Search for:

歐嘉隆台灣

在地報導

疫情削弱女性權益婦女節全體帶薪休假歐嘉隆關注女性健康

2022/03/08

TW-NON-110081 Jul/2022

Cookie 政策
隱私權政策
使用條款

© 2022 Organon group of companies. All rights reserved. ORGANON and the ORGANON Logo are trademarks of the Organon group of companies.

You are leaving Organon.com

Cancel Continue

Forward-looking statement of Organon

This news release of Organon (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov Opens a new window).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept